Ben Taylor serves as the Chief Financial Officer at Recursion Pharmaceuticals Inc, a biotechnology company focused on leveraging artificial intelligence and machine learning to accelerate drug discovery. With a robust background in finance and a keen understanding of the biotechnology sector, Taylor has been instrumental in guiding Recursion through its growth phases. He joined the company in 2019, bringing with him extensive experience in financial strategy and operations. Prior to his role at Recursion, Taylor held several high-profile positions in the finance sector. He spent over a decade at a leading investment bank, where he managed large-scale financial portfolios and advised on mergers and acquisitions within the life sciences industry. His strategic financial planning and deep industry knowledge have been pivotal in securing investments and fostering partnerships that have propelled Recursion's research and development efforts. Under his leadership, Recursion has successfully navigated the complexities of the biotech market, ensuring sustainable growth and innovation. As CFO, Taylor is responsible for overseeing all financial aspects of Recursion Pharmaceuticals, including budgeting, financial planning, and investor relations. His role is crucial in aligning the company's financial strategies with its long-term goals of revolutionizing drug discovery. Taylor's achievements include leading the company through a successful IPO and establishing a solid financial foundation that supports Recursion's ambitious projects. His leadership continues to be a driving force behind the company's mission to bring new therapies to patients faster and more efficiently.